ARS Pharmaceuticals, Inc. (SPRY)
NASDAQ: SPRY · Real-Time Price · USD
13.78
-0.86 (-5.87%)
Apr 25, 2025, 4:00 PM EDT - Market closed
ARS Pharmaceuticals Market Cap
ARS Pharmaceuticals has a market cap or net worth of $1.35 billion as of April 25, 2025. Its market cap has increased by 50.17% in one year.
Market Cap
1.35B
Enterprise Value
1.11B
1-Year Change
50.17%
Ranking
Category
Stock Price
$13.78
Market Cap Chart
Since November 9, 2022, ARS Pharmaceuticals's market cap has increased from $568.25M to $1.35B, an increase of 137.94%. That is a compound annual growth rate of 42.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2025 | 1.44B | 40.10% |
| Dec 31, 2024 | 1.03B | 94.90% |
| Dec 29, 2023 | 526.06M | -34.23% |
| Dec 30, 2022 | 799.86M | 40.76% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 767.41B |
| UnitedHealth Group | 388.35B |
| Johnson & Johnson | 371.43B |
| AbbVie | 320.11B |
| Novo Nordisk | 276.62B |
| Abbott Laboratories | 225.17B |
| AstraZeneca | 213.42B |
| Novartis AG | 208.99B |